ONCODEcipher Breast & Ovarian Premium NGS panel
Product Description:
FFPE DNA & blood panel targeting relevant and actionable genes commonly mutated in breast & ovarian cancer to provide treatment options & prognostic indications.
Highlighted Genes -- Somatic BRCA1 & BRCA2, ESR1, PIK3CA, TP53, NR-21, NR-24, BAT-25, BAT-26, MONO-27 (immunotherapy), MLH1, MSH2, MSH6 and etc.
Technique:
Next Generation Sequencing (NGS)
Test Methodology:
Cell free DNA extracted from plasma is subjected to amplification-based library preparation and massively parallel sequencing. Sequencing analysis is performed using commercial bioinformatics pipelines and annotation is done using proprietary and public databases.
Specimen Requirements:
- 3ml Blood in EDTA tubes
- FFPE Block or 10 Unstained Slides
- 1 H&E Stained Slide
- HPE report
Turn Around Time:
10-15 Working Days
3-4 weeks (For germline results)
Shipment Requirement:
Keep specimens at room temperature. DO NOT ship on ice or dry ice or expose to direct sunlight.